Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by NeuroPace, Inc.

News headline image
NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS® System Indication for Idiopathic Generalized Epilepsy
From NeuroPace, Inc.
Via Business Wire
Tickers NPCE
News headline image
NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy
From NeuroPace, Inc.
Via Business Wire
Tickers NPCE
News headline image
NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting
From NeuroPace, Inc.
Via Business Wire
Tickers NPCE
News headline image
NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services
From NeuroPace, Inc.
Via Business Wire
Tickers NPCE
News headline image
NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
From NeuroPace, Inc.
Via Business Wire
Tickers NPCE
News headline image
NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025
From NeuroPace, Inc.
Via Business Wire
Tickers NPCE
News headline image
NeuroPace to Participate in Upcoming Healthcare Conferences
From NeuroPace, Inc.
Via Business Wire
Tickers NPCE
News headline image
NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace Announces RNS System Enhancements Designed to Streamline Care
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace to Participate in Upcoming Investor Conferences
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace Announces Inducement Grants Under Listing Rule 5635(c)(4) of The Nasdaq Stock Market
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace to Report Second Quarter 2023 Financial Results on August 8, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace Announces CEO Transition
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace Reports Fourth Quarter & Full Year 2022 Financial Results
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
News headline image
NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
From NeuroPace, Inc.
Via GlobeNewswire
Tickers NPCE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.